Joanna Wykrzykowska

Joanna Wykrzykowska

Interventional cardiologist / Cardiologist
Universitair Medisch Centrum Groningen - Groningen, Netherlands

Latest contributions

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

21 May 2025 – From EuroPCR 2025

This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

Which valve is best for my patient?

21 May 2025 – From EuroPCR 2025

This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.

Which valve is best for my patient?

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

The future is now: QFR and RMS to optimise coronary artery disease patient management

20 May 2025 – From EuroPCR 2025

See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...

The future is now: QFR and RMS to optimise coronary artery disease patient management

Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve

24 Nov 2024 – From PCR London Valves 2024

Gain insights into the importance of valve optimization post-implantation to secure acute and long-term outcomes. In this session, you will discover the new features and benefits of the ACURATE Prime platform illustrated by a recorded case, and compare how different TAVI platforms perform when treating larger...

Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve

Stentless bifurcation PCI: what does the future hold?

25 Sep 2024

Watch the replay of this webinar on contemporary challenges in bifurcation PCI in case examples and so much more!

Other coronary interventions: SSO2, angioPy & more

16 May 2024 – From EuroPCR 2024

This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....

Other coronary interventions: SSO2, angioPy & more

These EuroIntervention papers changed my practice!

15 May 2024 – From EuroPCR 2024

These EuroIntervention papers changed my practice!

QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab

15 May 2024 – From EuroPCR 2024

Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...

QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Selecting the right first valve to secure lifetime management

17 May 2023 – From EuroPCR 2023

The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...

Left main bifurcation treatment with Ultrathin Supraflex Cruz stent: from non-invasive angiography to invasive assessment of anatomy and physiology

16 May 2023 – From EuroPCR 2023

In this session, experience a multimodality approach, including CTA, angiography and OCT, and learn how to reestablish good hemodynamic of the bifurcation, by analyzing the case of an 81-year-old man with no risk factors, no relevant comorbidities, and no treatment, who presented with crescendo effort angina.

Remaining unmet needs and strategies in TAVI

28 Nov 2022 – From PCR London Valves 2022

Watch this session to understand why valve design impacts future patient outcomes and how hemodynamics can impact decision-making and the durability of the TAVI devices. At the end of the session, you'll also get an overview of Medtronic's portfolio.

PROTECTED TAVR – Impact on Clinical Practice

03 Oct 2022

Watch the replay of this webinar to understand interpreting PTAVR in a practical manner to reflect clinical practice, and much more!

PCR Innovators Day - Machine learning and artificial intelligence

19 May 2022 – From EuroPCR 2022

Learn more about machine learning and artificial intelligence for automated assessment of CAD, risk assessment and early patient stratification, continuous monitoring of cardiac performance, and much more!

PCR Innovators Day - Machine learning and artificial intelligence

Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES

19 May 2022 – From EuroPCR 2022

Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

18 May 2022 – From EuroPCR 2022

What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release

18 May 2022 – From EuroPCR 2022

Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.

Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release

Patient risk factors and outcome in contemporary TAVI

17 May 2022 – From EuroPCR 2022

Watch these videos to learn more about the patient's risk factors and outcome after TAVI in various situations: with atrial fibrillation and history of PCI, with Diabetes Mellitus, with aortic stenosis based on cardiac damage, and more!

Patient risk factors and outcome in contemporary TAVI

Removing aspirin from STEMI patients - Can we improve bleeding without compromising on results?

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 recording by Yoshinobu Onuma, Joanna Wykrzykowska, and Victor Alfonso Jimenez to understand why monotherapy following STEMI can be beneficial for patients, and why aspirin should be eliminated from post-PCI care, and to learn about the ASET SUPREME study.

View more videos and course...

Removing aspirin from STEMI patients - Can we improve bleeding without compromising on results?

Coronary access after TAVI, a growing need

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...

Coronary access after TAVI, a growing need

DK crush technique for bifurcation PCI

18 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss which anatomy is suitable for DK Crush stenting, to learn the steps of DK Crush, and to review potential pitfalls of DK Crush.

This session was originally presented during EuroPCR 2021.

DK crush technique for bifurcation PCI

Is QFR ready for clinical decision making? QFR for making better long-term decisions with a novel DES

22 May 2019 – From EuroPCR 2019

Consult this session to learn the benefits of angio-based physiology and how to use it, and to review the quantitative Flow Ratio (QFR) results for BuMA Supreme.

Is QFR ready for clinical decision making? QFR for making better long-term decisions with a novel DES